Juan Andres - 03 Nov 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Technical Operations and Quality Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 03 Nov 2021
Transactions value $: -$1,688,950
Form type: 4
Filing time: 05 Nov 2021, 17:09:24
Previous filing: 02 Nov 2021
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$61.1K	+5K		$12.21^*	5K	03 Nov 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	-$1.75M	-5K	-100%	$350.00	0	03 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-5K	-3.85%	$0.00	125K	03 Nov 2021	Common Stock	5K	$12.21	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
F2	This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer